Pathology of Neurodegenerative Diseases.
暂无分享,去创建一个
[1] C. van Broeckhoven,et al. The Genetics of C9orf72 Expansions. , 2018, Cold Spring Harbor perspectives in medicine.
[2] W. Seeley. Mapping Neurodegenerative Disease Onset and Progression. , 2017, Cold Spring Harbor perspectives in biology.
[3] Alan J. Thomas,et al. Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.
[4] A. Goate,et al. Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease. , 2017, Cold Spring Harbor perspectives in medicine.
[5] V. Meininger,et al. Genetics of amyotrophic lateral sclerosis. , 2017, Revue neurologique.
[6] H. Kolb,et al. Tau Positron Emission Tomography Imaging. , 2017, Cold Spring Harbor perspectives in biology.
[7] D. Geschwind,et al. Molecular Genetics of Neurodegenerative Dementias. , 2017, Cold Spring Harbor perspectives in biology.
[8] I. Mackenzie,et al. Fused in Sarcoma Neuropathology in Neurodegenerative Disease. , 2017, Cold Spring Harbor perspectives in medicine.
[9] S. Prusiner,et al. Tau prions from Alzheimer’s disease and chronic traumatic encephalopathy patients propagate in cultured cells , 2016, Proceedings of the National Academy of Sciences.
[10] H. Braak,et al. Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases. , 2016, Cold Spring Harbor perspectives in biology.
[11] Knut Engedal,et al. Frontotemporal Dementia , 2016, Journal of geriatric psychiatry and neurology.
[12] E. Buratti,et al. Physiological functions and pathobiology of TDP‐43 and FUS/TLS proteins , 2016, Journal of neurochemistry.
[13] A. Goate,et al. Genetics of b -Amyloid Precursor Protein in Alzheimer’s Disease , 2016 .
[14] J. Trojanowski,et al. Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology , 2016, Acta Neuropathologica.
[15] Wayne A. Gordon,et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy , 2015, Acta Neuropathologica.
[16] Kevin F. Bieniek,et al. Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank , 2015, Acta Neuropathologica.
[17] D. Geschwind,et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism , 2015, Proceedings of the National Academy of Sciences.
[18] J. Parisi,et al. Expanding the spectrum of neuronal pathology in multiple system atrophy. , 2015, Brain : a journal of neurology.
[19] R. Cantu,et al. Chronic traumatic encephalopathy: historical origins and current perspective. , 2015, Annual review of clinical psychology.
[20] G. Kovacs,et al. Invited review: Neuropathology of tauopathies: principles and practice , 2015, Neuropathology and applied neurobiology.
[21] Thomas Wisniewski,et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy , 2015, Acta Neuropathologica.
[22] Janna H. Neltner,et al. Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.
[23] T. Hortobágyi,et al. Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium , 2014, Journal of Neural Transmission.
[24] H. Shill,et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease , 2014, Neurology.
[25] L. Petrucelli,et al. Acetylation: a new key to unlock tau’s role in neurodegeneration , 2014, Alzheimer's Research & Therapy.
[26] H. Shill,et al. Concomitant pathologies among a spectrum of parkinsonian disorders. , 2014, Parkinsonism & related disorders.
[27] J. Jankovic,et al. Parkinson disease subtypes. , 2014, JAMA neurology.
[28] Thomas G Beach,et al. Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. , 2014, Journal of neuropathology and experimental neurology.
[29] R. Coleman,et al. Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. , 2014, Journal of neuropathology and experimental neurology.
[30] C. Jack,et al. Staging TDP-43 pathology in Alzheimer’s disease , 2014, Acta Neuropathologica.
[31] John L. Robinson,et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD) , 2014, Acta Neuropathologica.
[32] S. Prusiner,et al. Transmission of multiple system atrophy prions to transgenic mice , 2013, Proceedings of the National Academy of Sciences.
[33] Ann C. McKee,et al. Clinical presentation of chronic traumatic encephalopathy , 2013, Neurology.
[34] Murray Grossman,et al. Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis , 2013, Annals of neurology.
[35] Michel Goedert,et al. Tau pathology and neurodegeneration , 2013, The Lancet Neurology.
[36] T. Beach,et al. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies , 2013, Acta Neuropathologica.
[37] E. Masliah,et al. Spongiform Change in Dementia With Lewy Bodies and Alzheimer Disease , 2013, Alzheimer disease and associated disorders.
[38] Mark Hallett,et al. Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.
[39] D. Ellison. Neuropathology : a reference text of CNS pathology , 1998 .
[40] A. McKee,et al. The spectrum of disease in chronic traumatic encephalopathy. , 2013, Brain : a journal of neurology.
[41] I. Milenkovic,et al. Incidental corticobasal degeneration in a 76-year-old woman. , 2013, Clinical neuropathology.
[42] Ranjan Duara,et al. Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia , 2012, Acta Neuropathologica.
[43] E. Mandelkow,et al. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. , 2012, Cold Spring Harbor perspectives in medicine.
[44] W. Kukull,et al. Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 , 2012, Journal of neuropathology and experimental neurology.
[45] Thomas G Beach,et al. Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging. , 2012, Journal of Parkinson's disease.
[46] O. Yokota,et al. Pick's disease. , 2012, Advances in experimental medicine and biology.
[47] J. Highley,et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology , 2011, Acta Neuropathologica.
[48] Dietmar R. Thal,et al. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.
[49] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[50] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[51] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[52] Dennis W. Dickson,et al. Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) , 2011, Journal of Molecular Neuroscience.
[53] D. Dickson,et al. Neuropathology underlying clinical variability in patients with synucleinopathies , 2011, Acta Neuropathologica.
[54] J. Trojanowski,et al. A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.
[55] Thomas G Beach,et al. Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? , 2011, Parkinsonism & related disorders.
[56] D. Maraganore,et al. Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? , 2011, Neurobiology of Aging.
[57] Jennifer L. Whitwell,et al. Corticobasal degeneration: a pathologically distinct 4R tauopathy , 2011, Nature Reviews Neurology.
[58] F. Terro,et al. Post-translational modifications of tau protein: Implications for Alzheimer's disease , 2011, Neurochemistry International.
[59] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[60] D. Dickson,et al. Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies , 2010, Acta Neuropathologica.
[61] D. Dickson,et al. Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.
[62] H. Shill,et al. Incidental Lewy body disease: Clinical comparison to a control cohort , 2010, Movement disorders : official journal of the Movement Disorder Society.
[63] Beat Meier,et al. Prions , 2010 .
[64] C. Jack,et al. Symmetric corticobasal degeneration (S-CBD). , 2010, Parkinsonism & related disorders.
[65] John Q. Trojanowski,et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update , 2009, Acta Neuropathologica.
[66] T Revesz,et al. A clinico-pathological study of subtypes in Parkinson's disease. , 2009, Brain : a journal of neurology.
[67] A. McKee,et al. Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury , 2009, Journal of neuropathology and experimental neurology.
[68] H. Shill,et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction , 2009, Acta Neuropathologica.
[69] Andrew King,et al. Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium , 2009, Acta Neuropathologica.
[70] David R Williams,et al. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges , 2009, The Lancet Neurology.
[71] Andrew King,et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. , 2009, Acta neuropathologica.
[72] Y. Hirayasu,et al. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease , 2009, Acta Neuropathologica.
[73] A. Pestronk,et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[74] C. Jack,et al. MRI correlates of neurofibrillary tangle pathology at autopsy , 2008, Neurology.
[75] P Sandroni,et al. Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.
[76] I. Grundke‐Iqbal,et al. Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. , 2008, Current Alzheimer research.
[77] William T. Hu,et al. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease , 2008, Acta Neuropathologica.
[78] D. Dickson,et al. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions , 2008, Acta Neuropathologica.
[79] Clifford R. Jack,et al. Argyrophilic grains: A distinct disease or an additive pathology? , 2008, Neurobiology of Aging.
[80] C. Jack,et al. β‐amyloid burden is not associated with rates of brain atrophy , 2008, Annals of neurology.
[81] G. Halliday,et al. The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.
[82] D. Dickson,et al. Differential incorporation of tau isoforms in Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.
[83] D. Dickson,et al. TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.
[84] T. Montine,et al. Proteomic Identification of Novel Proteins in Cortical Lewy Bodies , 2007, Brain pathology.
[85] N. Cairns,et al. TDP‐43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations , 2007, Journal of neuropathology and experimental neurology.
[86] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[87] J. Trojanowski,et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. , 2006, The American journal of pathology.
[88] Julie S. Snowden,et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.
[89] Dennis W. Dickson,et al. Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy , 2006, Journal of neuropathology and experimental neurology.
[90] M. Onofrj,et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.
[91] E. Tangalos,et al. Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.
[92] D. Dickson,et al. Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease Process , 2006, Journal of neuropathology and experimental neurology.
[93] A. Klug,et al. Tau protein, the paired helical filament and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[94] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[95] P. Lantos,et al. Overlap between neurodegenerative disorders , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.
[96] H. Akiyama,et al. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods , 2005, Acta Neuropathologica.
[97] Giampaolo Merlini,et al. Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of Amyloidosis , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[98] A. Andreadis. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. , 2005, Biochimica et biophysica acta.
[99] M. Tolnay,et al. Argyrophilic grain disease: A late‐onset dementia with distinctive features among tauopathies , 2004, Neuropathology : official journal of the Japanese Society of Neuropathology.
[100] D. Dickson,et al. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. , 2004, Archives of neurology.
[101] Udo Rüb,et al. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe , 2004, Neurobiology of Aging.
[102] H. Akiyama,et al. Identification of amino‐terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration , 2004, Annals of neurology.
[103] J. Morrison,et al. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases , 2004, Acta Neuropathologica.
[104] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[105] E. Kuusisto,et al. Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α‐Synuclein, Ubiquitin, and p62 , 2003, Journal of neuropathology and experimental neurology.
[106] D. Dickson,et al. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.
[107] D. Dickson,et al. Colocalization of Tau and Alpha‐Synuclein Epitopes in Lewy Bodies , 2003, Journal of neuropathology and experimental neurology.
[108] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[109] P. Lantos,et al. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.
[110] Catherine Lomen-Hoerth,et al. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.
[111] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[112] D. Dickson,et al. Argyrophilic Grain Disease Is a Sporadic 4‐Repeat Tauopathy , 2002, Journal of neuropathology and experimental neurology.
[113] D. Dickson,et al. Argyrophilic Grain Disease: Neuropathology, Frequency in a Dementia Brain Bank and Lack of Relationship with Apolipoprotein E , 2002, Brain pathology.
[114] D. Dickson. α-Synuclein and the Lewy body disorders , 2001 .
[115] D. Dickson,et al. Alpha-synuclein and the Lewy body disorders. , 2001, Current opinion in neurology.
[116] J. Trojanowski,et al. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease , 2001, Acta Neuropathologica.
[117] M. Staufenbiel,et al. Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* , 2001, The Journal of Biological Chemistry.
[118] L. Martinian,et al. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. , 2001, The American journal of pathology.
[119] L. Hakamies,et al. [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.
[120] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[121] Patrick R. Hof,et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.
[122] T Bek,et al. A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[123] Agueda Rostagno,et al. A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.
[124] P. Lantos,et al. The definition of multiple system atrophy: a review of recent developments. , 1998, Journal of neuropathology and experimental neurology.
[125] J. Hardy,et al. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau , 1998, Nature Neuroscience.
[126] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[127] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[128] A. Probst,et al. Ballooned neurons expressing αB-crystallin as a constant feature of the amygdala in argyrophilic grain disease , 1998, Neuroscience Letters.
[129] B. Hyman,et al. Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.
[130] D. Dickson. Pick's Disease: A Modern Approach , 1998, Brain pathology.
[131] J. Trojanowski,et al. Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.
[132] J. Trojanowski,et al. Monoclonal antibodies to purified cortical lewy bodies recognize the mid‐size neurofilament subunit , 1997, Annals of neurology.
[133] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[134] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[135] D. Dickson,et al. The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.
[136] T. Iwatsubo,et al. Association of A beta 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[137] K. Jellinger,et al. Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) , 1995, Brain pathology.
[138] D W Dickson,et al. Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.
[139] G. Giaccone,et al. Gerstmann‐Sträussler‐Scheinker Disease and the Indiana Kindred , 1995, Brain pathology.
[140] A. Kertesz,et al. The pathology and nosology of primary progressive aphasia , 1994, Neurology.
[141] Y. Ihara,et al. Posttranslational modifications of tau in paired helical filaments. , 1994, Dementia.
[142] Kenji Ikeda,et al. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy , 1994, Neuroscience Letters.
[143] D. Sparks,et al. Neurochemical and Histopathologic Alterations Characteristic of Pick's Disease in a Non-demented Individual , 1994, Journal of neuropathology and experimental neurology.
[144] E. Masliah,et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[145] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[146] D. Goldgaber,et al. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[147] G. Schellenberg,et al. A prion protein variant in a family with the telencephalic form of Gerstmann‐Sträussler‐Scheinker syndrome , 1991, Neurology.
[148] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[149] G. W. Roberts. IMMUNOCYTOCHEMISTRY OF NEUROFIBRILLARY TANGLES IN DEMENTIA PUGILISTICA AND ALZHEIMER'S DISEASE: EVIDENCE FOR COMMON GENESIS , 1988, The Lancet.
[150] F. Tagliavini,et al. Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals , 1988, Neuroscience Letters.
[151] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[152] H. Braak,et al. Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes , 1987, Neuroscience Letters.
[153] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[154] H. Wiśniewski,et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.
[155] H. Braak,et al. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques , 1986, Neuroscience Letters.
[156] A. Frankfurter,et al. The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.
[157] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[158] K Kosaka,et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.
[159] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[160] T. Reese. Synaptic vesicle exocytosis. , 1981, JAMA.
[161] K. Chapman. Letter: Monoamniotic twins. , 1974, Lancet.
[162] R. Tissot,et al. Pick's disease. Histological and clinical correlations. , 1974, European neurology.
[163] E. Richardson,et al. Corticodentatonigral degeneration with neuronal achromasia. , 1968, Archives of neurology.